Work

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2014.07.006

Authors: J.B. Auliac, C. Chouaid, L. Greiller, I. Monnet, H. Le Caer, L. Falchero, R. Corre, R. Descourt, S. Bota, H. Berard, R. Schott, A. Bizieux, P. Fournel, A. Labrunie, B. Marin, A. Vergnenegre

Institutions: Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Marseille, Hôpital Intercommunal de Créteil, Centre Hospitalier de la Dracénie, Hôpital Pontchaillou, Hôpital Charles-Nicolle, Institut Strauss, Institute Cancer De La Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Limoges

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2129904284

FWCI: 2.181

Cites: 33

Cited by: 20

Related to: 10